1 |
SARS-CoV-2 rS/Matrix M1-Adjuvant (Full length recombinant SARS-CoV-2 glycoprotein nano particle vaccine adjuvant with Matrix M) |
Novavax |
NCT04611802 EUCTR2020-004123-16-GB NCT04583995 |
2 |
Recombinant SARS-CoV-2 vaccine (CHO Cell)This is not a pattern of ‘ctgov’ external object linking. |
Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences |
NCT04646590 |
3 |
KBP-COVID-19 (RBD-based) |
Kentucky Bioprocessing Inc. |
NCT04473690 |
4 |
VAT00002: SARS-CoV-2 S protein with adjuvant |
Sanofi Pasteur + GSK |
PACTR202011523101903 |
5 |
SCB-2019 + AS03 or CpG 1018 adjuvant plus Alum adjuvant (Native like Trimeric subunit Spike Protein vaccine) |
Clover Biopharmaceuticals Inc./GSK/Dynavax |
NCT04672395 |
6 |
COVAX-19® Recombinant spike protein + adjuvant |
Vaxine Pty Ltd. |
NCT04453852 |
7 |
MVC-COV1901 (S-2P protein + CpG 1018) |
Medigen Vaccine Biologics + Dynavax + National Institute of Allergy and Infectious Diseases (NIAID) |
NCT04695652 |
8 |
FINLAY-FR1 anti-SARS-CoV-2 Vaccine (RBD + adjuvant) |
Instituto Finlay de Vacunas |
RPCEC00000332 |
9 |
FINLAY-FR-2 anti-SARS-CoV-2 Vaccine (RBD chemically conjugated to tetanus toxoid plus adjuvant) |
Instituto Finlay de Vacunas |
RPCEC00000354 |
10 |
EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19) |
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology “Vector” |
NCT04780035 |
11 |
RBD (baculovirus production expressed in Sf9 cells) Recombinant SARS-CoV-2 vaccine (Sf9 Cell) |
West China Hospital + Sichuan University |
NCT04718467 |
12 |
IMP CoVac-1 (SARS-CoV-2 HLA-DR peptides) |
University Hospital Tuebingen |
NCT04546841 |
13 |
UB-612 (Multitope peptide based S1-RBD-protein based vaccine) |
COVAXX + United Biomedical Inc |
NCT04683224 |
14 |
AdimrSC-2f (Recombinant RBD +/- Aluminium) |
Adimmune Corporation |
NCT04522089 |
15 |
CIGB-669 (RBD + AgnHB) |
Center for Genetic Engineering and Biotechnology (CIGB) |
RPCEC00000345 |
16 |
CIGB-66 (RBD + aluminium hydroxide) |
Center for Genetic Engineering and Biotechnology (CIGB) |
RPCEC00000359 |
17 |
Recombinant Sars-CoV-2 Spike protein, Aluminum adjuvanted |
Nanogen Pharmaceutical Biotechnology |
NCT04683484 |
18 |
Recombinant protein vaccine S-268019 (using Baculovirus expression vector system) |
Shionogi |
jRCT2051200092 |
19 |
SARS-CoV-2-RBD-Fc fusion protein |
University Medical Center Groningen + Akston Biosciences Inc. |
NCT04681092 |
20 |
COVAC-1 and COVAC-2 sub-unit vaccine (spike protein) + SWE adjuvant |
University of Saskatchewan |
NCT04702178 |
21 |
GBP510, a recombinant surface protein vaccine with adjuvant AS03 (aluminium hydroxide) |
SK Biosciences Co. Ltd. And CEPI |
NCT04750343 |
22 |
Razi Cov Pars, recombinant spike protein |
Razi Vaccine and Serum Research Institute |
IRCT20201214049709N1 |
23 |
MF59 adjuvanted SARS-CoV-2 Sclamp vaccine |
The University of Queensland |
NCT04495933 |
24 |
SK SARS-CoV-2 recombinant surface antigen protein subunit (NBP2001) + adjuvanted with alum |
SK Bioscience Co., Ltd. |
NCT04760743 |
25 |
SpFN (spike ferritin nanoparticle) uses spike proteins with a liposomal formulation QS21 (ALFQ) adjuvant. |
Walter Reed Army Institute of Research (WRAIR) |
NCT04784767 |
26 |
EuCorVac-19; A spike protein using the recombinant protein technology and with an adjuvant. |
POP Biotechnologies and EuBiologics Co.,Ltd |
NCT04783311 |
27 |
ReCOV: Recombinant two-component spike and RBD protein COVID-19 vaccine (CHO cell). |
Jiangsu Rec-Biotechnology |
NCT04818801 |